Lupin informs about press release

14 Nov 2025 Evaluate
Lupin has informed that it enclosed a Press Release titled ‘Lupin Launches Risperidone Long-Acting Injectable with 180- day CGT exclusivity in the U.S., the First Product from its Proprietary Long-Acting Injectable Platform PrecisionSphere’.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2103.50 11.55 (0.55%)
05-Dec-2025 15:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1806.00
Dr. Reddys Lab 1278.00
Cipla 1521.25
Zydus Lifesciences 932.30
Lupin 2103.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×